Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

Market Cap	11.15B
Revenue (ttm)	6.38B
Net Income (ttm)	595.75M
Shares Out	2.46B
EPS (ttm)	0.23
PE Ratio	19.64
Forward PE	n/a
Dividend	0.15 (3.33%)
Ex-Dividend Date	Jun 25, 2025

Volume	34,101,316
Average Volume	44,597,161
Open	4.510
Previous Close	4.510
Day's Range	4.500 - 4.560
52-Week Range	3.910 - 5.410
Beta	0.28
RSI	41.71
Earnings Date	Aug 28, 2025

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 8,411
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600572

Financial Performance

In 2024, SHA:600572's revenue was 6.52 billion, a decrease of -3.23% compared to the previous year's 6.73 billion. Earnings were 622.42 million, an increase of 5.21%.